David Marotta, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 S Anniston Ave, Sylacauga, AL 35150 Phone: 256-207-0200 Fax: 256-207-0209 |
Mr. Charles E. Singleton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 West Spring Street, Suite 300, Sylacauga, AL 35150 Phone: 256-245-8100 Fax: 256-245-9138 |
James L Crook, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 209 W Spring St Ste 300, Sylacauga, AL 35150 Phone: 256-245-8100 Fax: 256-245-9138 |
Mr. Juan Campos, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 S Anniston Ave, Sylacauga, AL 35150 Phone: 256-207-0200 Fax: 256-207-0201 |
Jonathan Lance Overcash, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 S Anniston Ave, Sylacauga, AL 35150 Phone: 256-207-0200 Fax: 256-207-0201 |
Matthew Ryan Dimon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 S Anniston Ave, Sylacauga, AL 35150 Phone: 256-207-0200 Fax: 256-207-0201 |
News Archive
According to a systematic review of existing studies, to appear in the May 4 issue of the Journal of the American Medical Association, the surgical procedure known as an episiotomy, performed in up to 35 percent of U.S. vaginal births, usually provides no benefits.
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis, according to research from The Netherlands and the USA presented today (Monday 28 June) at the 20th annual meeting of the European Society of Human Reproduction and Embryology.
Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.
PPD and Southern Research Institute today announced they have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development to provide clients a full spectrum of influenza vaccine development services by collaborating on client bids and projects.
› Verified 5 days ago